SH2 Domain Containing 4A (SH2D4A) (N-Term) Peptid
Kurzübersicht für SH2 Domain Containing 4A (SH2D4A) (N-Term) Peptid (ABIN8111581)
Target
Spezies
Quelle
Applikation
-
-
Protein Region
- N-Term
-
Verwendungszweck
- SH2D4A Peptide - N-terminal region
-
Sequenz
- IWKKVAEKEE LEQGSRPAPT LEEEKIRSLS SSSRNIQQML ADSINRMKAY
-
-
-
-
Applikationshinweise
- Optimal working dilution should be determined by the investigator.
-
Kommentare
-
This is a synthetic peptide designed for use in combination with anti-SH2D4A Antibody (ARP66275_P050),. It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications. Please inquire for more details.
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Lyophilized
-
Rekonstitution
- Add 100 µL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.
-
Buffer
- Lyophilized powder
-
Lagerung
- -20 °C
-
Informationen zur Lagerung
- For longer periods of storage, store at -20 °C. Avoid repeat freeze-thaw cycles.
-
-
- SH2D4A (SH2 Domain Containing 4A (SH2D4A))
-
Hintergrund
-
Background Information: SH2D4A inhibits estrogen-induced cell proliferation by competing with PLCG for binding to ESR1, blocking the effect of estrogen on PLCG and repressing estrogen-induced proliferation. SH2D4A may play a role in T-cell development and function.
Alternative Symbols: FLJ20967, SH2A, PPP1R38
-
Molekulargewicht
- 53kDa
-
Gen-ID
- 63898
-
NCBI Accession
- NP_071354
-
UniProt
- Q9H788
Target
-